203 related articles for article (PubMed ID: 27345657)
1. Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.
Scheel A; Bellile E; McHugh JB; Walline HM; Prince ME; Urba S; Wolf GT; Eisbruch A; Worden F; Carey TE; Bradford C
Laryngoscope; 2016 Sep; 126(9):E292-9. PubMed ID: 27345657
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer.
Kumar B; Cordell KG; D'Silva N; Prince ME; Adams ME; Fisher SG; Wolf GT; Carey TE; Bradford CR
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):363-9. PubMed ID: 18427001
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in advanced larynx cancer.
Bradford CR; Kumar B; Bellile E; Lee J; Taylor J; D'Silva N; Cordell K; Kleer C; Kupfer R; Kumar P; Urba S; Worden F; Eisbruch A; Wolf GT; Teknos TN; Prince ME; Chepeha DB; Hogikyan ND; Moyer JS; Carey TE
Laryngoscope; 2014 Jan; 124(1):179-87. PubMed ID: 23775802
[TBL] [Abstract][Full Text] [Related]
4. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.
Kumar B; Cordell KG; Lee JS; Worden FP; Prince ME; Tran HH; Wolf GT; Urba SG; Chepeha DB; Teknos TN; Eisbruch A; Tsien CI; Taylor JM; D'Silva NJ; Yang K; Kurnit DM; Bauer JA; Bradford CR; Carey TE
J Clin Oncol; 2008 Jul; 26(19):3128-37. PubMed ID: 18474878
[TBL] [Abstract][Full Text] [Related]
5. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
Geisler S; Lønning PE; Aas T; Johnsen H; Fluge O; Haugen DF; Lillehaug JR; Akslen LA; Børresen-Dale AL
Cancer Res; 2001 Mar; 61(6):2505-12. PubMed ID: 11289122
[TBL] [Abstract][Full Text] [Related]
6. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
[TBL] [Abstract][Full Text] [Related]
8. HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common.
Kashofer K; Winter E; Halbwedl I; Thueringer A; Kreiner M; Sauer S; Regauer S
Mod Pathol; 2017 Jul; 30(7):1013-1020. PubMed ID: 28387325
[TBL] [Abstract][Full Text] [Related]
9. Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non-small cell lung cancer.
Jiang W; Cheng H; Yu L; Zhang J; Wang Y; Liang Y; Lou F; Wang H; Cao S
Cancer Med; 2023 Mar; 12(6):6649-6658. PubMed ID: 36440695
[TBL] [Abstract][Full Text] [Related]
10. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
[TBL] [Abstract][Full Text] [Related]
11. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors.
Manjarrez ME; Ocadiz R; Valle L; Pacheco C; Marroquin A; De la Torre C; Selman M; Gariglio P
Clin Cancer Res; 2006 Dec; 12(23):6946-51. PubMed ID: 17145812
[TBL] [Abstract][Full Text] [Related]
12. Assessment of HPV 16, HPV 18, p16 expression in advanced stage laryngeal cancer patients and prognostic significance.
Dogantemur S; Ozdemir S; Uguz A; Surmelioglu O; Dagkiran M; Tarkan O; Tuncer U
Braz J Otorhinolaryngol; 2020; 86(3):351-357. PubMed ID: 31899126
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
[TBL] [Abstract][Full Text] [Related]
14. TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.
Malisic E; Jankovic R; Jakovljevic K; Radulovic S
J BUON; 2011; 16(4):701-7. PubMed ID: 22331725
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.
Wang Z; Xia RH; Ye DX; Li J
PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915
[TBL] [Abstract][Full Text] [Related]
16. Potential clinical implications of HPV status and expressions of p53 and cyclin D1 among oropharyngeal cancer patients.
Lu XJD; Liu KYP; Soares RC; Thomson T; Prisman E; Wu J; Poh CF
J Oral Pathol Med; 2018 Nov; 47(10):945-953. PubMed ID: 30191616
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Prognostic Value of HPV among Tunisian Patients with Laryngeal Cancer and Relationship between DNA HPV and p16, IGF-1R, Survivin, p53 Expressions.
Ben Elhadj M; Fourati A; El Amine O; Goucha A; El May A; El May MV; Mokni Baizig N
Ann Otol Rhinol Laryngol; 2020 Sep; 129(9):863-871. PubMed ID: 32364419
[TBL] [Abstract][Full Text] [Related]
18. Effect of human papillomavirus on cell cycle-related proteins p16INK4A, p21waf1/cip1, p53 and cyclin D1 in sinonasal inverted papilloma and laryngeal carcinoma. An in situ hybridization study.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
Folia Histochem Cytobiol; 2011; 49(1):34-40. PubMed ID: 21526487
[TBL] [Abstract][Full Text] [Related]
19. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
Kashofer K; Regauer S
Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
Huang Q; Li F; Ji M; Lin L; Hu C
BMC Cancer; 2023 Apr; 23(1):324. PubMed ID: 37024846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]